| Trial ID: | L6618 |
| Source ID: | NCT00159211
|
| Associated Drug: |
Umuline Nph
|
| Title: |
Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: UMULINE NPH|DRUG: pioglitazone
|
| Outcome Measures: |
Primary: Abdominal adipose tissue (on scan) variation at 6 month, 6 months | Secondary: Cellularity of subcutaneous adipose variation tissue at 6 month, 6 months|HbA1c, lipid level, adiponectin, CRP variation at 6 month, 6 months|inflammation gene expression in sub-cutaneous fat, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Assistance Publique - Hôpitaux de Paris | Collaborators: Laboratoires Takeda
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
28
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-05
|
| Completion Date: |
2007-05
|
| Results First Posted: |
|
| Last Update Posted: |
2007-11-08
|
| Locations: |
Sce de Diabétologie, hôpital de la Pitié-salpêtrière, 83bld de l'hôpital, Paris, 75013, France
|
| URL: |
https://clinicaltrials.gov/show/NCT00159211
|
